413 filings
Page 5 of 21
8-K
zrv9ws
6 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
8-K
22u5288
15 Nov 21
Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update
8:30am
8-K
3fmv99jsj96dgw
12 Nov 21
Departure of Directors or Certain Officers
6:02am
8-K
t2rf 1f6rrm
29 Oct 21
Departure of Directors or Certain Officers
4:05pm
8-K
z74xny8k
29 Sep 21
Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update
8:15am
S-8
x7qh5
28 Sep 21
Registration of securities for employees
4:36pm
8-K
78xv 6kavea
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
424B5
f876ka
27 Sep 21
Prospectus supplement for primary offering
5:28pm
8-K
9fvltptfqy8 fz8e
7 Sep 21
Other Events
5:28pm
8-K
kmhe37 i8s
28 Jun 21
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
osphen9n0
14 May 21
Kintara Therapeutics Announces Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update
8:17am
8-K
vh534lmx
3 May 21
Departure of Directors or Certain Officers
4:05pm
EFFECT
kcqtmf mwl9lx93vfn
2 Apr 21
Notice of effectiveness
12:15am
CORRESP
fvq ob1ajy15v
30 Mar 21
Correspondence with SEC
12:00am
UPLOAD
wmwty1r3v cc
30 Mar 21
Letter from SEC
12:00am